Contribute Try STAT+ Today

Good morning, everyone, and how are you today? We are doing just fine, thank you, courtesy of a shiny sun and cool breeze enveloping the Pharmalot campus. As usual, we are brewing cups of stimulation and foraging for items of interest, which we have assembled below as you can see. One quick note: Given the pending holiday on this side of the pond, we will suspend our morning newsletter until Monday. For those of you who have a scheduled respite, we hope you enjoy. Meanwhile, have a wonderful day. …

As President Trump presses to make health care a central plank of his 2020 reelection bid, he is displaying mounting frustration with those he thinks are thwarting his ability to deliver on a major campaign promise: lowering drug prices, The Washington Post tells us. That has included Health and Human Services Secretary Alex Azar, a former drug executive who until very recently pushed back on proposals to import lower-cost drugs from Canada and negotiate drug prices in Medicare. Under pressure, Azar is reversing some of his positions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.